BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24464713)

  • 21. Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies.
    Stene LC; Rewers M
    Clin Exp Immunol; 2012 Apr; 168(1):12-23. PubMed ID: 22385232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus.
    D'Alessio DJ
    Am J Epidemiol; 1992 Jun; 135(12):1331-8. PubMed ID: 1324601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunology of viral diabetes.
    Babu PG; Huber SA; Craighead JE
    Surv Synth Pathol Res; 1985; 4(1):1-7. PubMed ID: 2992061
    [No Abstract]   [Full Text] [Related]  

  • 24. [Type 1 diabetes mellitus--an infectious disease?].
    Mandrup-Poulsen TR
    Ugeskr Laeger; 2002 Dec; 164(50):5936-40. PubMed ID: 12553115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 1 diabetes and Coxsackie virus infection.
    Di Pietro C; Del Guercio MJ; Paolino GP; Barbi M; Ferrante P; Chiumello G
    Helv Paediatr Acta; 1979; 34(6):557-61. PubMed ID: 232095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases.
    Sauter P; Hober D
    Microbes Infect; 2009 Apr; 11(4):443-51. PubMed ID: 19399964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence.
    Barrett-Connor E
    Rev Infect Dis; 1985; 7(2):207-15. PubMed ID: 2988099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-Coxsakie B viruses humoral immunity status in patients with pancreatic diseases].
    Trukhan DI
    Vopr Virusol; 2001; 46(2):33-6. PubMed ID: 11392968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse Models of Virus-Induced Type 1 Diabetes.
    Christoffersson G; Flodström-Tullberg M
    Methods Mol Biol; 2020; 2128():93-105. PubMed ID: 32180188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B.
    Hyöty H; Leon F; Knip M
    Expert Rev Vaccines; 2018 Dec; 17(12):1071-1083. PubMed ID: 30449209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The viral triggering of autoimmune disease.
    Wekerle H
    Nat Med; 1998 Jul; 4(7):770-1. PubMed ID: 9662363
    [No Abstract]   [Full Text] [Related]  

  • 32. Alteration in CD8
    Zargari Samani O; Mahmoodnia L; Izad M; Shirzad H; Jamshidian A; Ghatrehsamani M; Kheiri S; Sadeghian L; Soltani A; Sarmadi A
    Kaohsiung J Med Sci; 2018 May; 34(5):274-280. PubMed ID: 29699634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 1 diabetes: virus infection or autoimmune disease?
    Fairweather D; Rose NR
    Nat Immunol; 2002 Apr; 3(4):338-40. PubMed ID: 11919574
    [No Abstract]   [Full Text] [Related]  

  • 34. The pathogenesis of viral-induced diabetes.
    See DM; Tilles JG
    Clin Diagn Virol; 1998 Apr; 9(2-3):85-8. PubMed ID: 9645989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple viruses in diabetes mellitus.
    Jenson AB; Rosenberg HS
    Prog Med Virol; 1984; 29():197-217. PubMed ID: 6322233
    [No Abstract]   [Full Text] [Related]  

  • 36. An enterovirus strain isolated from diabetic child belongs to a genetic subcluster of echovirus 11, but is also neutralised with monotypic antisera to coxsackievirus A9.
    Al-Hello H; Paananen A; Eskelinen M; Ylipaasto P; Hovi T; Salmela K; Lukashev AN; Bobegamage S; Roivainen M
    J Gen Virol; 2008 Aug; 89(Pt 8):1949-1959. PubMed ID: 18632967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coxsackie B virus and postviral fatigue syndrome.
    Muir P; Nicholson F; Banatvala JE; Bingley PJ
    BMJ; 1991 Mar; 302(6777):658-9. PubMed ID: 1849432
    [No Abstract]   [Full Text] [Related]  

  • 38. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group.
    Hyöty H; Hiltunen M; Knip M; Laakkonen M; Vähäsalo P; Karjalainen J; Koskela P; Roivainen M; Leinikki P; Hovi T
    Diabetes; 1995 Jun; 44(6):652-7. PubMed ID: 7789630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
    Sané F; Moumna I; Hober D
    Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroepidemiological evidence of widespread enteroviral infection in Anambra State, Nigeria.
    Iroegbu CU
    Arch Roum Pathol Exp Microbiol; 1990; 49(1):63-9. PubMed ID: 1966236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.